Press release

DSM reports H1 2017 results

Heerlen, NL, 01 Aug 2017 07:00 CEST

Highlights H1

  • Continued good performance in Q2 concludes very strong H1
  • Sales up 11% to €4,320m, with 8% organic growth
  • Adjusted EBITDA up 16% to €721m, driven by both Nutrition and Materials
  • ROCE up 170 bps to 12.2%
  • Net profit up 42% to €312m
  • Interim dividend of €0.58 per ordinary share
  • Outlook 2017: slightly improved

Key figures and indicators

in € millionH1 2017H1 2016% changeVolumePrice/mixFXOther
Sales4,3203,90711%6%2%3%0%
Nutrition2,7782,5459%5%1%3%0%
Materials1,4261,24015%8%5%1%1%
Adjusted EBITDA72162416%    
Nutrition52846214%    
Materials24121214%    
EBITDA689603     
ROCE (%)112.2%10.5%     

1) January up until June

CEO statement

Feike Sijbesma, CEO/Chairman of the DSM Managing Board, commented: “DSM maintained its positive momentum with a very strong first half-year performance. The second quarter was another very good quarter.

Halfway through Strategy 2018, we are well ahead of our targets. All businesses are delivering on their growth initiatives, helping us outpace the market; we increasingly provide our customers with innovative solutions, resulting in a continued shift toward specialties. Furthermore, we are fully on track with our wide-ranging cost-reduction and efficiency improvement programs, while anchoring the high-performance culture we strive for. We also continued to make good progress with our sustainability agenda, future-proofing our operations and delivering products and solutions which help our customers to make their businesses more sustainable. The expected Patheon transaction demonstrates our commitment to monetize the significant value within our associates and earlier than anticipated.

While being mindful of the volatile macro-economic environment and the higher-base results achieved since 2015, we are confident for the remainder of the year and have increased our outlook for the full year."

Outlook 2017 slightly improved

DSM now expects to deliver full-year 2017 results above the targets set out in its Strategy 2018, with an EBITDA growth for the year moving slightly up from high single-digit to double digit, and with a ROCE increase moving from double digit basis points to over 100 basis points.

Q2 Highlights

  • DSM reports a very good Q2
  • Sales up 8% to €2,161m, with 6% organic growth
  • Adjusted EBITDA up 15% to €376m
  • Nutrition: 4% organic sales growth; Adjusted EBITDA up 14%
  • Materials: 4% volume growth; Adjusted EBITDA up 9%

Key figures and indicators

in € millionQ2 2017Q2 2016% changeVolumePrice/mixFXOther
Sales2,1611,9948%4%2%2%0%
Nutrition1,3801,2957%4%0%3%0%
Materials72564013%4%7%1%1%
Adjusted EBITDA37632815%    
Nutrition27123714%    
Materials1281179%    
EBITDA355332     
ROCE (%)112.2%10.5%     

1) January up until June

Key figures and indicators

in € millionH1 2017H1 2016% changeVolumePrice/mixFXOther
Sales4,3203,90711%6%2%3%0%
Nutrition2,7782,5459%5%1%3%0%
Materials1,4261,24015%8%5%1%1%
Innovation Center84831%6%-6%1%0%
Corporate Activities3239     
in € millionQ2 2017Q2 2016% changeVolumePrice/mixFXOther
Sales2,1611,9948%4%2%2%0%
Nutrition1,3801,2957%4%0%3%0%
Materials72564013%4%7%1%1%
Innovation Center41403%9%-7%1%0%
Corporate Activities1519     
in € millionH1 2017H1 2016% changeQ2 2017Q2 2016% change
Sales4,3203,90711%2,1611,9948%
Adjusted EBITDA72162416%37632815%
Nutrition52846214%27123714%
Materials24121214%1281179%
Innovation Center11 00 
Corporate Activities-49-51 -23-26 
Adjusted EBITDA margin16.7%16.0% 17.4%16.4% 
EBITDA689603 355332 
Adjusted EBIT47839621%25621121%
EBIT441375 235215 
Capital Employed7,6927,616    
Average Capital Employed7,8317,542    
ROCE  (%)12.2%10.5%    
Effective tax rate18.0%18.5%    
Adjusted net profit33824439%17513530%
Net profit - Total DSM31222042%16313521%
Adjusted net EPS1.901.3640%0.980.7629%
Net EPS - Total DSM1.751.22 0.910.76 
Cash Flow3293193%133182-27%
Capital Expenditures1250177 12078 
Net debt2,2052,466    

1) Cash, net of customer funding
In this report:
a) ‘Organic sales growth’ is the total impact of volume and price/mix;
b) ‘Total Working Capital’ refers to the total of ‘Operating Working Capital’ and ‘non-Operating Working Capital'

The complete version of this press release with accompanying financial statements and the Presentation to Investors are below in PDF format.

For more information

Lieke de Jong-Tops

Senior Communications Manager
+31 45 578 2420
media.contacts@dsm.com

Dave Huizing

Vice President Investor Relations
+31 45 578 2864
investor.relations@dsm.com

Lieke de Jong-Tops

Senior Communications Manager
+31 45 578 2420

Dave Huizing

Vice-President Investor Relations
+31 45 578 2864